Mutations of TGFbeta signaling molecules in human disease

Kelly A Harradine1, Rosemary J Akhurst

  • 1Cancer Research Institute, Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA.

Annals of Medicine
|September 30, 2006
PubMed

Insights

Transforming growth factor beta (TGFbeta) signaling impacts cell functions and development. Mutations in TGFbeta signaling cause congenital disorders and cancer, with outcomes influenced by genetics and environment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • The transforming growth factor beta (TGFbeta) signaling pathway is crucial for regulating cellular proliferation, differentiation, apoptosis, migration, and extracellular matrix deposition.
  • TGFbeta signaling involves two main Smad branches: TGFbeta/activin to Smad2/3 and bone morphogenetic protein (BMP) to Smad1/5, ultimately modifying cytoskeletal organization and gene expression.

Purpose of the Study:

  • To review the molecular etiology of TGFbeta-associated disorders.
  • To discuss clinical overlap between syndromes and explain variable penetrance and expressivity.
  • To explore how understanding genotype-phenotype correlations can improve diagnostics and therapeutics for TGFbeta-related diseases.

Main Methods:

  • Literature review of molecular mechanisms and clinical manifestations of TGFbeta signaling pathway disruptions.
  • Analysis of genotype-phenotype correlations in hereditary congenital malformations, dysfunctions, and cancer predisposition syndromes.
  • Examination of factors influencing disease outcome, including environmental influences and genetic background.

Main Results:

  • Germline disruption of TGFbeta signaling is linked to skeletal, muscular, and cardiovascular system defects, as well as cancer predisposition.
  • Clinical presentation of TGFbeta-associated disorders shows significant variability, influenced by environmental factors and individual genetic makeup.
  • Understanding the molecular basis of TGFbeta signaling is key to developing better prognostic tools and personalized treatment strategies.

Conclusions:

  • TGFbeta signaling pathway mutations underlie a spectrum of congenital disorders and cancers.
  • Variable expressivity and penetrance in these disorders are modulated by genetic background and environmental factors.
  • Further research into TGFbeta signaling mechanisms will facilitate individualized disease management and therapeutic development for related conditions.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...